Literature DB >> 1820473

Incidence and risk factors for gout in white men.

R Roubenoff1, M J Klag, L A Mead, K Y Liang, A J Seidler, M C Hochberg.   

Abstract

OBJECTIVE: To identify potentially modifiable risk factors for the development of gout.
DESIGN: Longitudinal cohort study (The Johns Hopkins Precursors Study). PARTICIPANTS: Of 1337 eligible medical students, 1271 (95%) received a standardized medical examination and questionnaire during medical school. The participants were predominantly male (91%), white (97%), and young (median age, 22 years) at cohort entry. OUTCOME MEASURE: The development of gout.
RESULTS: Sixty cases of gout (47 primary and 13 secondary) were identified among 1216 men; none occurred among 121 women (P = .01). The cumulative incidence of all gout was 8.6% among men (95% confidence interval, 5.9% to 11.3%). Body mass index at age 35 years (P = .01), excessive weight gain (greater than 1.88 kg/m2) between cohort entry and age 35 years (P = .007), and development of hypertension (P = .004) were significant risk factors for all gout in univariate analysis. Multivariate Cox proportional hazards models confirmed the association of body mass index at age 35 years (relative risk [RR] = 1.12; P = .02), excessive weight gain (RR = 2.07; P = .02), and hypertension (RR = 3.26; P = .002) as risk factors for all gout. Hypertension, however, was not a significant risk factor for primary gout.
CONCLUSIONS: Obesity, excessive weight gain in young adulthood, and hypertension are risk factors for the development of gout. Prevention of obesity and hypertension may decrease the incidence of and morbidity from gout; studies of weight reduction in the primary and secondary prevention of gout are indicated.

Entities:  

Mesh:

Year:  1991        PMID: 1820473

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  57 in total

Review 1.  The epidemiology of uric acid and fructose.

Authors:  Young Hee Rho; Yanyan Zhu; Hyon K Choi
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 2.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Diet, alcohol, and gout: how do we advise patients given recent developments?

Authors:  Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 4.  Recent advances in the epidemiology of gout.

Authors:  Kenneth G Saag; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 5.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 6.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 7.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Prevention and management of gout.

Authors:  V L Star; M C Hochberg
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

9.  Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects.

Authors:  Reza Khosravan; Brian Grabowski; Jing-Tao Wu; Nancy Joseph-Ridge; Laurent Vernillet
Journal:  Br J Clin Pharmacol       Date:  2007-10-22       Impact factor: 4.335

10.  Interleukin-1beta gene polymorphisms in Taiwanese patients with gout.

Authors:  Man-Ling Chen; Chung-Ming Huang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2003-12-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.